𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effector mechanism of human monocyte-mediated cytotoxicity: role of a new tumor cytotoxic factor distinct from interleukin 1 and tumor necrosis factorα

✍ Scribed by Saburo Sone; Masanobu Munekata; Makoto Tanaka; Teruhiro Utsugi; Takeshi Ogura

Publisher
Springer
Year
1989
Tongue
English
Weight
974 KB
Volume
1
Category
Article
ISSN
0921-299X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti-parasitic effector mechanisms in hu
Anti-parasitic effector mechanisms in human brain tumor cells: Role of interferon-γ and tumor necrosis factor-α
✍ Walter Däubener; Christine Remscheid; Susanne Nockemann; Korinna Pilz; Samira Se 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 673 KB

Toxoplasrna gondii, an obligate intracellular parasite, is able to replicate in human brain cells. We recently showed that interferon (1FN)-y-activated cells from glioblastoma line 86HG39 were able to restrict Toxoplusma growth. The effector mechanism responsible for this toxoplasmostatic effect was

Interleukin-1β- and tumor necrosis facto
Interleukin-1β- and tumor necrosis factor-α-independent monocyte stimulation of fibroblast collagenase activity
✍ David A. Tipton; Michael J. Pabst; Mustafa Kh. Dabbous 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 856 KB

## Abstract To investigate the mechanism of cyclosporine (Cs)‐induced fibrous gingival enlargement, the indirect effects of Cs on fibroblast collagenolysis via the drug's effect on the synthesis of the fibroblast regulatory monokines interleukin‐1β (IL‐1β) and tumor necrosis factor‐α (TNFα) have be

Stimulation of the hyaluronic acid level
Stimulation of the hyaluronic acid levels of human synovial fibroblasts by recombinant human tumor necrosis factor α, tumor necrosis factor β (lymphotoxin), interleukin-1α, and interleukin-1β
✍ Debra M. Butler; Gerard F. Vitti; Tali Leizer; John A. Hamilton 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 873 KB

Monocyte/macrophage polypeptides (monokines) alter the properties of synovial cells. This interaction could explain some of the properties of the inflamed synovium in rheumatic disease. Only recently has it been possible to test the action of purified monokines on the target synovial cells. We repor